MDMA Capitol Hill Advocacy Role Accentuated By Incoming President Holden
This article was originally published in The Gray Sheet
Executive Summary
MDMA is emphasizing political savvy over device industry experience in its appointment of Rep. Christopher Shays' (R-Conn.) former chief of staff, Larry Holden, as president of the Medical Device Manufacturers Association, effective Nov. 1.
You may also be interested in...
Acting Commish II: Crawford Assumes FDA Helm As McClellan Heads To CMS
FDA Deputy Commissioner Lester Crawford, PhD, will head a reorganized agency following Commissioner Mark McClellan's move to the Centers for Medicare & Medicaid Services
Acting Commish II: Crawford Assumes FDA Helm As McClellan Heads To CMS
FDA Deputy Commissioner Lester Crawford, PhD, will head a reorganized agency following Commissioner Mark McClellan's move to the Centers for Medicare & Medicaid Services
Third-Party Reviews Should Be Used Only If Expertise Is Lacking – MDMA
The Medical Device Manufacturers Association is seeking to toughen FDA device reform legislation to prevent outside expert reviews of PMAs from occurring unless the agency lacks resources to conduct the reviews in-house